Spectra Biomedical Overview

  • Founded
  • 1993
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $9M
Latest Deal Amount

Spectra Biomedical General Information


Operator of a biotechnology company focused on neurological conditions. The company provides research into the genetic basis of certain neurological conditions, including migraine headaches.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 4040 Campbell Avenue
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Spectra Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jun-1997 $9M 000 Completed Clinical Trials - General
1. Early Stage VC Completed Clinical Trials - General
To view Spectra Biomedical’s complete valuation and funding history, request access »

Spectra Biomedical Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Avalon Ventures Venture Capital Minority 000 0000 000000 0
To view Spectra Biomedical’s complete investors history, request access »